Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Nature Communications|February 13, 2021
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasmsJason R Schwartz, Jing Ma, Jennifer Kamens, et al.Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.Blood|January 26, 2026
Uncovering the genomic complexity of PAX5 intragenic tandem multiplication via long-read and short-read sequencingYanling Liu, Bensheng Ju, Li Dong, et al.Nature Communications|November 3, 2017
Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.Nature Communications|February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.Cell Genomics|November 17, 2022
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractorS M Ashiqul Islam, Marcos Díaz-Gay, Yang Wu, et al.Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.Blood|November 8, 2019
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemiaBenshang Li, Samuel W Brady, Xiaotu Ma, et al.Cancer Discovery|July 24, 2021
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA SequencingScott Newman, Joy Nakitandwe, Chimene A Kesserwan, et al.Cancer Discovery|January 7, 2021
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing EcosystemClay McLeod, Alexander M Gout, Xin Zhou, et al.Pageof 5